KIORA PHARMACEUTICALS INC
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Delaware
- Sector
- Other
- Headquarters
- Encinitas, CA
- Street
- 169 Saxony Rd.
- Zip
- 92024
Offering
- Total offering
- $5M
- Amount sold
- $5M
- First sale
- Apr 6, 2026
- Min investment
- $0
- Securities
- Equity
- Federal exemption
- Rule 506(b)
- Investors so far
- 3
How this filing compares
Ranked #241 of 611 Other filings in April 2026 by offering amount.
Median Other filing in April 2026: $4.3M. This offering is 1.2× the median.
Other California filings this week: 444 Capital - D'Amelio Family Fund I, LP, Angeles Private Markets Fund 6 LP, AQT Capital Fund, LP, C1 Group LLC, Camden Bonds Plus Fund, LLC
Leadership
Brian Strem — Executive Officer
Melissa Tosca — Executive Officer
Carmine Stengone — Director
Aron Shapiro — Director
Lisa Walters-Hoffert — Director
Praveen Tyle — Director
David Hollander — Director
Erin Parsons — Director
Filing details
KIORA PHARMACEUTICALS INC filed a Form D with the SEC on April 21, 2026.